MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijcard.2024.131948

Медицинская библиотека · International journal of cardiology · 2024

Outcomes for patients undergoing transcatheter aortic valve replacement with ascending aorta dilation.

Feng Dejing, Zhao Jie, Niu Guannan, Zhang Yuxuan, Wang Can, Chen Yang, Zhou Zheng, Zhang Hongliang, Zhao Zhenyan, Ye Yunqing, Li Zhe, Xu Haiyan, Wang Moyang, Wu Yongjian

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

We aim to compare the short and long-term outcomes for aortic stenosis (AS) patients undergone TAVR with and without ascending aorta dilation (AAD).

METHODS

Consecutive patients diagnosed with native severe AS who underwent TAVR from September 2012 to September 2021 were enrolled. They were stratified into the moderate/severe dilation group (greatest ascending aorta width ≥ 45 mm) and the non/mild dilation group. Survival outcomes were illustrated using Kaplan-Meier curves and evaluated with the log-rank test. Data from patients with CT follow-up of >6 months was used to investigate the progression rate of AAD.

RESULTS

The study cohort comprised 556 patients, with a mean age of 75.5 ± 7.3 years. Among them, 107 patients (19.2%) had a moderate/severe AAD (≥45 mm), with an average diameter of 48.6 mm (±2.8). During hospitalization, both groups witnessed two cases of ascending aortic dissection (1.9% vs 0.4%, P = 0.380). The median follow-up duration was 3.9 years (95% CI: 3.8-4.0 years). No deaths were caused by aortic events and no patients experienced a new aortic dissection. The AAD cohort's 4-year all-cause and cardiovascular mortality rates were not significantly different to the non/mild dilation group's (log-rank test, P = 0.109 and P = 0.698, respectively). Follow-up CT data revealed that the rate of aortic dilation progression in the moderate/severe dilation group was not significantly different from that in the non/mild group (0.0 mm/year, 25-75%th: -0.3-0.2 vs 0.1 mm/year, 25-75%th: -0.3-0.4, P = 0.122).

CONCLUSION

This study found no significant difference regarding short-term and long-term outcomes in AS patients with/without moderate/severe AAD undergoing TAVR.

Для цитирования: Feng Dejing, Zhao Jie, Niu Guannan, Zhang Yuxuan, Wang Can, Chen Yang, Zhou Zheng, Zhang Hongliang, Zhao Zhenyan, Ye Yunqing, Li Zhe, Xu Haiyan, Wang Moyang, Wu Yongjian. Outcomes for patients undergoing transcatheter aortic valve replacement with ascending aorta dilation.. International journal of cardiology. 2024. DOI: 10.1016/j.ijcard.2024.131948.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.